This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Turning Point Therapeutics, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Inventor Spotlight: Nathan V. Lee
Introduction
Nathan V. Lee is an innovative inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his research and development of unique therapeutic approaches.
Latest Patents
Nathan V. Lee holds a patent for a "Combination therapy involving diaryl macrocyclic compounds." This patent focuses on methods and compositions for treating cancer, particularly through the use of a diaryl macrocycle in conjunction with an inhibitor of MAPK/ERK kinase-1 and -2 (MEK1 and MEK2). This groundbreaking work aims to enhance the efficacy of existing treatments, such as trametinib.
Career Highlights
Currently, Nathan is associated with Turning Point Therapeutics, Inc., where he continues to push the boundaries of cancer research and treatment. His work represents a key advancement in the search for more effective cancer therapies.
Collaborations
In his endeavors, Nathan collaborates with esteemed colleagues such as Wei Deng and Dayong Zhai. Their collective expertise contributes to the innovative research environment at Turning Point Therapeutics, Inc.
Conclusion
Nathan V. Lee's dedication and contributions to cancer treatment exemplify the essential role of inventors in the field of medicine. His innovative approach to combination therapies holds promise for improved outcomes in cancer care, and his patent reflects a significant step forward in the fight against this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile